S-Homocysteinylation of transthyretin is detected in plasma and serum of humans with different types of hyperhomocysteinemia

被引:33
作者
Sass, JO
Nakanishi, T
Sato, T
Sperl, W
Shimizu, A
机构
[1] Univ Freiburg Klinikum, Zentrum Kinderheilkunde & Jugendmed, Stoffwechsellabor, D-79106 Freiburg, Germany
[2] Osaka Med Coll, Dept Clin Pathol, Osaka 5698686, Japan
[3] Landeskliniken Salzburg, St Johanns Spital, Landesklin Kinder & Jugendheilkunde, A-5020 Salzburg, Austria
关键词
homocysteine; homocysteine thiolactone; homocysteinylation; lysine; vitamin B-12; cobalamin; folate; transthyretin; high pressure liquid chromatography-electrospray ionization mass spectrometry;
D O I
10.1016/j.bbrc.2003.08.089
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
While the association of homocystinuria with disease is known for more than four decades, mild hyperhomocysteinemia has been detected more recently as a risk factor for a number of diseases. However, the mechanism which apparently renders (even mild) hyperhomocystenemia harmful is not known. Following reports on N-homocysteinylation of proteins by the homocysteine derivative homocysteine thiolactone, it has been suggested that homocysteinylation of proteins may contribute to the induction of biological effects by homocysteine. This has prompted us to study by electrospray ionization mass spectrometry homocysteinylation of transthyretin (TTR) in plasma and serum of humans with different types of hyperhomocysteinemia. We did not detect any N-homocysteinylation, but found pronounced S-homocysteinylation of TTR, if the concentration of total homocysteine was high. Our findings support a possible role of S-homocysteinylation of proteins in the mediation of detrimental effects of hyperhomocysteinemia. Careful study of posttranslational modifications of individual proteins may contribute to a better understanding of diseases associated with hyperhomocysteinemia. (C) 2003 Elsevier Inc. All rights reserved.
引用
收藏
页码:242 / 246
页数:5
相关论文
共 27 条
[1]  
Ferguson E, 1998, J LIPID RES, V39, P925
[2]   The importance of hyperhomocysteinemia as a risk factor for diseases: An overview [J].
Herrmann, W .
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2001, 39 (08) :666-674
[3]   Homocysteine thiolactone and protein homocysteinylation: mechanistic studies with model peptides and proteins [J].
Hop, CECA ;
Bakhtiar, R .
RAPID COMMUNICATIONS IN MASS SPECTROMETRY, 2002, 16 (11) :1049-1053
[4]   Calcium-dependent human serum homocysteine thiolactone hydrolase -: A protective mechanism against protein N-homocysteinylation [J].
Jakubowski, H .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (06) :3957-3962
[5]   Homocysteine thiolactone and protein homocysteinylation in human endothelial cells - Implications for atherosclerosis [J].
Jakubowski, H ;
Zhang, L ;
Bardeguez, A ;
Aviv, A .
CIRCULATION RESEARCH, 2000, 87 (01) :45-51
[6]  
Jakubowski H, 1997, J BIOL CHEM, V272, P1935
[7]   Homocysteine is a protein amino acid in humans - Implications for homocysteine-linked disease [J].
Jakubowski, H .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (34) :30425-30428
[8]   Aminoacylation of coenzyme A and pantetheine by aminoacyl-tRNA synthetases: Possible link between noncoded and coded peptide synthesis [J].
Jakubowski, H .
BIOCHEMISTRY, 1998, 37 (15) :5147-5153
[9]   Translational accuracy of aminoacyl-tRNA synthetases: Implications for atherosclerosis [J].
Jakubowski, H .
JOURNAL OF NUTRITION, 2001, 131 (11) :2983S-2987S
[10]   Genetic determinants of homocysteine thiolactonase activity in humans: implications for atherosclerosis [J].
Jakubowski, H ;
Ambrosius, WT ;
Pratt, JH .
FEBS LETTERS, 2001, 491 (1-2) :35-39